The mutation of CD28 exhibits improved safety in CAR T immunotherapy

ZHANG Ting-ting, WANG Tian, YOU Feng-tao, LI Zi-xuan, TIAN Shuai-yu, ZHANG Kai-lu, SHENG Bin-jie, WU Hai, AN Gang-li, MENG Hui-min, WANG Min, WANG Xing-bing, YANG Lin

PDF(1715 KB)
Welcome to Current Immunology, Today is
PDF(1715 KB)
Current Immunology ›› 2022, Vol. 42 ›› Issue (6) : 474-481.

The mutation of CD28 exhibits improved safety in CAR T immunotherapy

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 42(6): 474-481

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1715 KB)

Accesses

Citation

Detail
Sections
Recommended
Contact
Add: 1 / f, library 1, no.280, south chongqing road, Shangha
Code: 200025
Tel: 021-53062055
E-mail: currentimmunol@126.com
visited
Total visitors:
Visitors of today:
Now online:
Copyright © 2022 Current Immunology

/

〈 〉